The role of leptin on pancreatic cancer growth in vivo had previously been reported through experiments utilizing the LepDB (long form leptin receptor deficient) and LepOB (ligand deficient) mice that inherently develop obesity. Here, LEPR is linked to obesity due to melanocortin 4 receptor deficiency.